BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37976824)

  • 41. The effects of Micro-429 on inhibition of cervical cancer cells through targeting ZEB1 and CRKL.
    Wang Y; Dong X; Hu B; Wang XJ; Wang Q; Wang WL
    Biomed Pharmacother; 2016 May; 80():311-321. PubMed ID: 27133071
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Essential role of polymorphism of Gab1, EGFR, and EGF for the susceptibility of biliary tract cancer.
    Meng LQ
    Tumour Biol; 2014 Dec; 35(12):12497-508. PubMed ID: 25217982
    [TBL] [Abstract][Full Text] [Related]  

  • 43. EGFR Promoter Methylation, EGFR Mutation, and HPV Infection in Chinese Cervical Squamous Cell Carcinoma.
    Zhang W; Jiang Y; Yu Q; Qiang S; Liang P; Gao Y; Zhao X; Liu W; Zhang J
    Appl Immunohistochem Mol Morphol; 2015 Oct; 23(9):661-6. PubMed ID: 25789535
    [TBL] [Abstract][Full Text] [Related]  

  • 44. E2F7, EREG, miR-451a and miR-106b-5p are associated with the cervical cancer development.
    Zong S; Liu X; Zhou N; Yue Y
    Arch Gynecol Obstet; 2019 Apr; 299(4):1089-1098. PubMed ID: 30607582
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bioinformatics Analysis: The Regulatory Network of hsa_circ_0007843 and hsa_circ_0007331 in Colon Cancer.
    Han Z; Chen H; Guo Z; Zhu J; Xie X; Li Y; He J
    Biomed Res Int; 2021; 2021():6662897. PubMed ID: 34337040
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MiR-125a-5p inhibits EMT of ovarian cancer cells by regulating TAZ/EGFR signaling pathway.
    Cao Y; Shen T; Zhang C; Zhang QH; Zhang ZQ
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8249-8256. PubMed ID: 31646555
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Integrating network pharmacology approaches for the investigation of multi-target pharmacological mechanism of 6-shogaol against cervical cancer.
    Elasbali AM; Al-Soud WA; Mousa Elayyan AE; Al-Oanzi ZH; Alhassan HH; Mohamed BM; Alanazi HH; Ashraf MS; Moiz S; Patel M; Patel M; Adnan M
    J Biomol Struct Dyn; 2023; 41(23):14135-14151. PubMed ID: 36943780
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of the epidermal growth factor receptor by erlotinib prevents immortalization of human cervical cells by Human Papillomavirus type 16.
    Woodworth CD; Diefendorf LP; Jette DF; Mohammed A; Moses MA; Searleman SA; Stevens DA; Wilton KM; Mondal S
    Virology; 2011 Dec; 421(1):19-27. PubMed ID: 21982220
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Network pharmacology-based identification of miRNA expression of Astragalus membranaceus in the treatment of diabetic nephropathy.
    Dai Y; Guo M; Jiang L; Gao J
    Medicine (Baltimore); 2022 Feb; 101(5):e28747. PubMed ID: 35119030
    [TBL] [Abstract][Full Text] [Related]  

  • 50. miR-218-5p/RUNX2 Axis Positively Regulates Proliferation and Is Associated with Poor Prognosis in Cervical Cancer.
    Cruz-De la Rosa MI; Jiménez-Wences H; Alarcón-Millán J; Romero-López MJ; Castañón-Sánchez CA; Salmerón-Bárcenas EG; Fernández-Tilapa G
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805994
    [TBL] [Abstract][Full Text] [Related]  

  • 51. miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy.
    Adam L; Zhong M; Choi W; Qi W; Nicoloso M; Arora A; Calin G; Wang H; Siefker-Radtke A; McConkey D; Bar-Eli M; Dinney C
    Clin Cancer Res; 2009 Aug; 15(16):5060-72. PubMed ID: 19671845
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bioinformatics Analysis Predicts hsa_circ_0026337/miR-197-3p as a Potential Oncogenic ceRNA Network for Non-Small Cell Lung Cancers.
    Zhang Q; Kang L; Li X; Li Z; Wen S; Fu X
    Anticancer Agents Med Chem; 2022; 22(5):874-886. PubMed ID: 34254931
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The prognostic miR-532-5p-correlated ceRNA-mediated lipid droplet accumulation drives nodal metastasis of cervical cancer.
    Shang C; Li Y; He T; Liao Y; Du Q; Wang P; Qiao J; Guo H
    J Adv Res; 2022 Mar; 37():169-184. PubMed ID: 35499057
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human papilloma virus (HPV)-E6/E7 and epidermal growth factor receptor (EGF-R) protein levels in cervical cancer and cervical intraepithelial neoplasia (CIN).
    Mathur SP; Mathur RS; Rust PF; Young RC
    Am J Reprod Immunol; 2001 Oct; 46(4):280-7. PubMed ID: 11642677
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Construction of a circRNA-miRNA-mRNA Regulated Pathway Involved in EGFR-TKI Lung Adenocarcinoma Resistance.
    Dai C; Liu B; Li S; Hong Y; Si J; Xiong Y; Wu N; Ma Y
    Technol Cancer Res Treat; 2021; 20():15330338211056809. PubMed ID: 34825849
    [No Abstract]   [Full Text] [Related]  

  • 56. Hsa_circ_0031288/hsa-miR-139-3p/Bcl-6 regulatory feedback circuit influences the invasion and migration of cervical cancer HeLa cells.
    Xu YJ; Yu H; Liu GX
    J Cell Biochem; 2020 Oct; 121(10):4251-4260. PubMed ID: 32277518
    [TBL] [Abstract][Full Text] [Related]  

  • 57. EGCG attenuate EGF triggered matrix abundance and migration in HPV positive and HPV negative cervical cancer cells.
    Sabanayagam R; Krishnamoorthy S; Gnanagurusamy J; Muruganatham B; Muthusami S
    Med Oncol; 2023 Aug; 40(9):261. PubMed ID: 37544940
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hsa_circITGA4/ miR-1468/EGFR/ PTEN a Master Regulators Axis in Glioblastoma Development and Progression.
    Tutunchi S; Bereimipour A; Ghaderian SMH
    Mol Biotechnol; 2024 Jan; 66(1):90-101. PubMed ID: 37031335
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Coordinated targeting of the EGFR signaling axis by microRNA-27a*.
    Wu X; Bhayani MK; Dodge CT; Nicoloso MS; Chen Y; Yan X; Adachi M; Thomas L; Galer CE; Jiffar T; Pickering CR; Kupferman ME; Myers JN; Calin GA; Lai SY
    Oncotarget; 2013 Sep; 4(9):1388-98. PubMed ID: 23963114
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of miR-409-3p in regulation of HPV16/18-E6 mRNA in human cervical high-grade squamous intraepithelial lesions.
    Sommerova L; Anton M; Bouchalova P; Jasickova H; Rak V; Jandakova E; Selingerova I; Bartosik M; Vojtesek B; Hrstka R
    Antiviral Res; 2019 Mar; 163():185-192. PubMed ID: 30711417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.